Cefetamet sodium

Drug Profile

Cefetamet sodium

Alternative Names: cefetamet sodium salt; Sodium cefetamet

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hainan Eshun Pharmaceutical
  • Class Antibacterials; Cephalosporins
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Gram-negative infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Gram-negative-infections(In volunteers) in China (IV, Injection)
  • 24 Apr 2013 Final adverse events and pharmacokinetic data from a phase I trial in Bacterial infection (in volunteers) presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT-2013)
  • 09 Mar 2013 Phase-I clinical trials in Gram-negative infections in China (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top